Population-based study of risk of breast cancer in carriers of BRCA2 mutation-Reference-Cited by-同舟云学术

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

Published:1998-10 Issue:9137 Volume:352 Page:1337-1339
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Thorlacius Steinunn,Struewing Jeffery P,Hartage Patricia,Olafsdottir Gudridur H,Sigvaldason Helgi,Tryggvadottir Laufey,Wacholder Sholom,Tulinius Hrafn,Eyfjörd Jorunn E

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. A strong candidate for the breast and ovarian cancer susceptibility gene;Miki;BRCA1. Science,1994

2. Identification of the breast cancer susceptibility gene;Wooster;BRCA2. Nature,1995

3. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds;Tavtigian;Nat Genet,1996

4. Mutations and polymorphisms in the familiar early-onset breast cancer (BRCA1) gene: Breast Cancer Information Core;Couch;Hum Mutat,1996

5. Breast Cancer Linkage Consortium: breast and ovarian cancer incidence in BRCA1-mutation carriers;Easton;Am J Hum Genet,1995

Cited by 293 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CLINICOPATHOLOGICAL STUDY OF BREAST CANCER AND IMMUNOHISTOCHEMICAL EXPRESSION OF BRCA 1 AND BRCA2 – A PROSPECTIVE STUDY;Asian Journal of Pharmaceutical and Clinical Research;2024-01-07

2. Genetic Testing for Successive Cancer Treatment;Cureus;2023-12-04

3. Circulating and extracellular vesicle-derived microRNAs as biomarkers in bone-related diseases;Frontiers in Endocrinology;2023-05-24

4. The Contribution of Interleukin-8 Rs4073 Genotypes to Triple Negative Breast Cancer Risk in Taiwan;Anticancer Research;2022-07-26

5. High-throughput proteomics and AI for cancer biomarker discovery;Advanced Drug Delivery Reviews;2021-09